Palantir Technologies Inc. (NEO:PLTR)

Sage Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	929.55	2,099	831.05	2,599	2,291	2,011
Short-Term Investments	5,071	3,131	2,843	35.14	234.15	-
Cash & Short-Term Investments	6,000	5,230	3,674	2,634	2,525	2,011
Cash Growth	50.07%	42.34%	39.51%	4.31%	25.53%	86.38%
Receivables	747.48	575.05	364.78	258.35	190.92	156.93
Prepaid Expenses	133.47	121.55	99.29	149.56	110.87	51.89
Restricted Cash	9.02	7.7	0.37	-	36.63	37.29
Total Current Assets	6,890	5,934	4,139	3,042	2,863	2,257
Property, Plant & Equipment	247	240.38	230.62	269.41	248.2	246.62
Long-Term Investments	122.9	64.9	32.6	-	-	-
Other Intangible Assets	-	18.06	25.9	-	-	-
Other Long-Term Assets	105.4	83.26	94.68	150.25	136	186.46
Total Assets	7,366	6,341	4,522	3,461	3,247	2,691
Accounts Payable	10.77	0.1	12.12	44.79	74.91	16.36
Accrued Expenses	329.86	384.8	175.73	131.39	133.26	158.55
Current Portion of Leases	45.47	43.99	54.18	45.1	39.93	29.08
Current Income Taxes Payable	63.77	42.24	47.26	41.33	22.55	-
Current Unearned Revenue	376.78	259.62	246.9	183.35	227.82	189.52
Other Current Liabilities	262.99	265.25	209.83	141.99	161.61	210.32
Total Current Liabilities	1,090	996.02	746.02	587.94	660.06	603.82
Long-Term Debt	-	-	-	-	-	197.98
Long-Term Leases	192.35	195.23	175.22	204.31	220.15	229.8
Long-Term Unearned Revenue	44.64	39.89	28.05	9.97	40.22	50.53
Other Long-Term Liabilities	13.5	15.35	12.18	16.59	36	85.83
Total Liabilities	1,340	1,246	961.46	818.8	956.42	1,168
Common Stock	2.37	2.34	2.2	2.1	2.03	1.79
Additional Paid-In Capital	10,568	10,194	9,122	8,428	7,777	6,489
Retained Earnings	-4,647	-5,187	-5,650	-5,859	-5,486	-4,965
Comprehensive Income & Other	4.72	-5.61	0.8	-5.33	-2.35	-2.75
Total Common Equity	5,929	5,003	3,476	2,565	2,291	1,523
Minority Interest	96.66	91.13	85.4	77.11	-	-
Shareholders' Equity	6,026	5,094	3,561	2,642	2,291	1,523
Total Liabilities & Equity	7,366	6,341	4,522	3,461	3,247	2,691
Total Debt	237.81	239.22	229.39	249.4	260.07	456.86
Net Cash (Debt)	5,763	4,991	3,445	2,384	2,265	1,554
Net Cash Growth	54.08%	44.88%	44.48%	5.28%	45.69%	127.56%
Net Cash Per Share	2.28	2.04	1.50	1.16	1.18	1.59
Filing Date Shares Outstanding	2,372	2,345	2,213	2,101	2,030	1,822
Total Common Shares Outstanding	2,372	2,339	2,200	2,099	2,027	1,792
Working Capital	5,801	4,938	3,393	2,454	2,203	1,654
Book Value Per Share	2.50	2.14	1.58	1.22	1.13	0.85
Tangible Book Value	5,929	4,985	3,450	2,565	2,291	1,523
Tangible Book Value Per Share	2.50	2.13	1.57	1.22	1.13	0.85
Machinery	82.77	69.72	64.68	65.7	25.27	32.25
Construction In Progress	6.53	7.63	2.1	5.51	3.13	0.49
Leasehold Improvements	92.4	85.28	83.14	80.38	72.83	85.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.